In short. Adipose tissue contains cells, but a fat graft is regulated as a graft and behaves as one. The stem cell label is added after the operation, not by it.
Key points
- Many tissues contain cells that can divide.
- Finding them under a microscope is a laboratory observation about the tissue.
- Turning that observation into a treatment claim requires a product, a dose, a route and a controlled comparison, and a fat graft has none of those in the form the claim implies.
Fat grafting is an established operation with a long history. Fat is taken from one area with a cannula, processed in some way, and placed in another. It is used for contour, for volume and for reconstruction. Somewhere along the way it acquired a second name, and that name causes more confusion than the operation does.
What the graft actually is
A fat graft is tissue. It contains fat cells, connective tissue, blood vessels, fluid and a small population of cells that sit alongside the blood vessels. That last population is why the operation is sometimes described as a stem cell treatment. Its presence is real. Its significance for the result is not established, and the processing a graft undergoes before placement is designed for the graft rather than for those cells.
Why the graft behaves as a graft
Placed fat survives or it does not. What determines the outcome is the blood supply at the recipient site, how the fat is handled, how much is placed and how evenly it is spread. Fat that is not reached by a blood supply is resorbed, or it becomes a collection of dead tissue. This is graft behaviour, and it is what the operation is regulated as, planned as and judged by. The stem cell description does not change any of that.
A cell population inside a tissue is not a cell therapy
Many tissues contain cells that can divide. Finding them under a microscope is a laboratory observation about the tissue. Turning that observation into a treatment claim requires a product, a dose, a route and a controlled comparison, and a fat graft has none of those in the form the claim implies.
Where the label adds something
Two places, and neither is clinical. The label raises the price of a procedure that is otherwise priced as a graft. And it moves the conversation away from what the operation genuinely involves, which is a donor site, a processing step, a period of unpredictable survival, and a result that is partly reabsorbed. A reader told that a graft is a stem cell treatment is being invited to think about regeneration rather than about take rates and resorption.
Three questions that keep the operation in view
- What proportion of the placed fat is expected to survive, and how is that judged?
- What happens at the donor site, and how long is recovery there?
- If the result is uneven or too little, what is the plan, and is a second procedure likely?
None of this makes fat grafting a bad operation. It makes it an operation with its own behaviour, its own limits and its own risks, which is a more useful description than a borrowed name. The distinction matters most when somebody is choosing between a graft and an unapproved cell injection on the understanding that the two are variations of one thing. They are not. One is a tissue transfer with a defined regulatory position and decades of practice behind it. The other is neither.
Frequently asked questions
Does a fat graft contain stem cells?
Adipose tissue contains a small population of cells that sit alongside the blood vessels, and their presence is real. What is not established is that they determine the result. The graft survives or fails according to blood supply at the recipient site and how the fat is handled, placed and spread.
How is a fat graft regulated?
As a tissue transfer, which is why the operation is planned and judged as a graft. The processing a graft undergoes before placement is designed for the graft rather than for any cell population within it.
Why does the stem cell label matter if the operation is the same?
Because it moves the conversation away from what the operation involves. A reader told that a graft is a cell treatment is invited to think about regeneration rather than about the donor site, the period of unpredictable survival and the proportion of fat that is reabsorbed.
Risks & Limitations
- Transplantation is established medicine for defined blood and immune conditions; the cosmetic products that borrow the name mostly hold no approval for injection.
- An unapproved cell or tissue preparation usually cannot be identified with certainty and cannot be dissolved, so a result that is unwanted or a lump that forms may not be correctable by an injection.
- Reported harms of unapproved cell and tissue injections include infection at the injection site, collections of pus requiring drainage, prolonged swelling, nodules that do not settle and granuloma formation.
- A preparation made at the point of care has no release testing that a regulator has reviewed, and the cell content of what is injected is often not measured.
- There is no randomised comparison of a stem cell facelift against a placebo or against an established treatment, and no agreed definition of the procedure for a trial to test.
When to Seek Care
- Spreading redness, warmth, fever or discharge from an injection site. Have it assessed by a clinician without delay.
- A firm lump, persistent pain, or skin that is changing colour weeks or months after an injection.
- Any change in vision, or severe pain around the eye, needs emergency care immediately.
- Contact the service that performed the treatment first, and then seek an assessment by somebody who can examine the area.
References & Further Reading
- American Society of Plastic Surgeons (ASPS) — procedure and safety guidance
- National Institute for Health and Care Excellence (NICE, UK) — relevant guidance
- Cochrane Library — systematic reviews
- Chinese Medical Association Plastic Surgery Branch — clinical guidance
This page is patient education, not medical advice, and it does not cite individual studies. It reviews evidence and regulation; it is not a booking page and does not recommend a treatment. Discuss your own case with a qualified clinician. To ask a question about this review, see Contact & Consultation.